HUP9900951A3 - Process for producing tamoxifen and analogues thereof - Google Patents

Process for producing tamoxifen and analogues thereof

Info

Publication number
HUP9900951A3
HUP9900951A3 HU9900951A HUP9900951A HUP9900951A3 HU P9900951 A3 HUP9900951 A3 HU P9900951A3 HU 9900951 A HU9900951 A HU 9900951A HU P9900951 A HUP9900951 A HU P9900951A HU P9900951 A3 HUP9900951 A3 HU P9900951A3
Authority
HU
Hungary
Prior art keywords
tamoxifen
analogues
producing
producing tamoxifen
Prior art date
Application number
HU9900951A
Other languages
English (en)
Original Assignee
Bradford University Bradford
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9601167.1A external-priority patent/GB9601167D0/en
Application filed by Bradford University Bradford filed Critical Bradford University Bradford
Publication of HUP9900951A2 publication Critical patent/HUP9900951A2/hu
Publication of HUP9900951A3 publication Critical patent/HUP9900951A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/20Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU9900951A 1996-01-20 1997-01-20 Process for producing tamoxifen and analogues thereof HUP9900951A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9601167.1A GB9601167D0 (en) 1996-01-20 1996-01-20 Tamoxifen and analogues thereof
GB9618775A GB2309224B (en) 1996-01-20 1996-09-09 Tamoxifen and analogues thereof

Publications (2)

Publication Number Publication Date
HUP9900951A2 HUP9900951A2 (hu) 1999-09-28
HUP9900951A3 true HUP9900951A3 (en) 2000-02-28

Family

ID=26308500

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900951A HUP9900951A3 (en) 1996-01-20 1997-01-20 Process for producing tamoxifen and analogues thereof

Country Status (8)

Country Link
US (1) US6172263B1 (hu)
EP (1) EP0883587A1 (hu)
JP (1) JP2000503315A (hu)
AU (1) AU725286B2 (hu)
CA (1) CA2243330A1 (hu)
HU (1) HUP9900951A3 (hu)
NO (1) NO311346B1 (hu)
WO (1) WO1997026234A1 (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1579857A1 (en) 2004-03-22 2005-09-28 Laboratoires Besins International Chemically stable compositions of 4-hydroxy tamoxifen
WO2007056215A2 (en) * 2005-11-02 2007-05-18 Cytovia, Inc. N-aryl-thienopyrimidin-4-amines and the use thereof
EP2465498A1 (en) * 2010-11-23 2012-06-20 Faes Farma, S.A. Diphenyl-amine derivatives: uses, process of synthesis and pharmaceutical compositions
US11624095B2 (en) 2017-09-27 2023-04-11 Case Western Reserve University Method of quantifying HIV reservoirs by induced transcription based sequencing

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE637389A (hu) 1962-09-13
ATE25515T1 (de) * 1983-05-24 1987-03-15 Bristol Myers Co Verfahren zur umwandlung von 1,2-diphenyl-1-(4-(2-dimethylamino-ethoxy)-phen l>-1-buten-e-isomeren zu tamoxifen-hydrochlorid.
EP0168175B1 (en) 1984-06-12 1987-11-19 National Research Development Corporation Preparation of tamoxifen
ATE80152T1 (de) 1987-04-21 1992-09-15 Heumann Pharma Gmbh & Co Stabile loesungsmitteladdukte von z-1-(p-betadimethylamino-ethoxyphenyl)-1-(p-hydroxyphenyl) 2-phenylbut-1-en.
DE3736682A1 (de) 1987-10-29 1989-05-11 Klinge Co Chem Pharm Fab Verfahren zur herstellung von trans-1,1,2-triphenyl-but-1-en-derivaten
WO1995011879A1 (fr) * 1993-10-25 1995-05-04 Taiho Pharmaceutical Co., Ltd. Procede de production de sel d'addition d'acide d'isomere z de compose de triphenylethylene
ES2115207T3 (es) * 1994-01-03 1998-06-16 Klinge Co Chem Pharm Fab Metodo para la produccion de e-1-(4'-(2-dimetilaminoetoxi)-fenil)-1-(3'-hidroxifenil)-2-fenil-1-buteno.
GB9601167D0 (en) 1996-01-20 1996-03-20 Univ Bradford Tamoxifen and analogues thereof

Also Published As

Publication number Publication date
US6172263B1 (en) 2001-01-09
EP0883587A1 (en) 1998-12-16
NO311346B1 (no) 2001-11-19
AU725286B2 (en) 2000-10-12
NO983346D0 (no) 1998-07-20
WO1997026234A1 (en) 1997-07-24
HUP9900951A2 (hu) 1999-09-28
AU1395397A (en) 1997-08-11
NO983346L (no) 1998-09-17
JP2000503315A (ja) 2000-03-21
CA2243330A1 (en) 1997-07-24

Similar Documents

Publication Publication Date Title
HUP9903053A3 (en) Tramadol multiple unit formulations and process for producing them
HU9702508D0 (en) Vitronectin-receptor-antagonists and process for producing them
CZ11498A3 (cs) Střela a způsob její výroby
HUP9603179A3 (en) Process for producing benzyl-ethers
HUP9700140A3 (en) Process for producing 0-demethyl-tramadol-enantiomeres
HUP9801898A3 (en) Antipsoriatic nail-lack and process for producing it
HU9702509D0 (en) Vitronectin-receptor-antagonists and process for producing them
GB9722771D0 (en) A karyotyper and method for producing karyotypes
HUP9700380A3 (en) Process for producing 4-oxoimidazolinium-salts
GR3029933T3 (en) Process for producing n-arylhydroxylamines and n-hetarylhydroxylamines
HU9700212D0 (en) Process for producing alkyl-chlorides
HUP0003203A3 (en) Process for producing bisindolymalimides
HUP9901392A3 (en) Process for producing felodipine
HUP9904325A3 (en) Process for johexol manufacture
HUP9900951A3 (en) Process for producing tamoxifen and analogues thereof
HUP9602960A3 (en) Process for producing carbazates
HU9802054D0 (en) Process for producing pentafluorpentanol
EP0990639A4 (en) PROCESS FOR PRODUCING N-CYCLOPROPYLANILINES AND INTERMEDIATES USED IN THIS PROCESS
SG72861A1 (en) Process for producing 7-octen-1-al
HUP9802955A3 (en) Process for producing amino-cyano-acetamide
EP0990658A4 (en) PROCESS FOR PRODUCING TRIHYDROCARBYLALUMINUMS
HUP9700548A2 (en) Process for producing indenes
GB2309224B (en) Tamoxifen and analogues thereof
HU9502227D0 (en) 4-amino-3-hydroxy-phtalimidine and process for producing that
GB9610666D0 (en) Milk-shakes and process for making them